Literature DB >> 1662324

Visceral leishmaniasis in an HIV-infected patient: clinical features and response to treatment.

S Fenske1, H J Stellbrink, H Albrecht, H Greten.   

Abstract

We report the case of 43-year-old homosexual patient with HIV infection and a history of travel to the Far East in whom visceral leishmaniasis was the first infectious complication. Symptoms were fever, malaise, weight loss, hepatosplenomegaly, generalized lymphadenopathy, and oral thrush. Laboratory abnormalities included a slight elevation of liver enzymes, impairment of liver function tests, leukocytopenia, anemia, hypergammaglobulinemia, and markedly depressed CD4(+)-cell counts. Despite initially successful treatment with pentavalent antimony, a relapse of leishmaniasis occurred after 7 months. Eradication of the infection was not achieved. Treatment was continued as a palliative chronic suppressive treatment with fortnightly pentamidine infusions. The clinical course was complicated by legionella pneumonia and the development of rapidly progressing Kaposi's sarcoma. The case is presented in detail, and the influence of HIV infection on the course of leishmaniasis is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662324     DOI: 10.1007/bf01744270

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  [Visceral leishmaniasis in patients with AIDS. Description of 2 cases].

Authors:  G Federico; R Cauda; E Pizzigallo; G Ventura; L Ortona; A Capelli; L M Larocca; U Familiari
Journal:  Pathologica       Date:  1989 Nov-Dec

2.  Profound CD4+ lymphocytopenia in the absence of HIV infection in a patient with visceral leishmaniasis.

Authors:  G Cozon; T Greenland; J P Revillard
Journal:  N Engl J Med       Date:  1990-01-11       Impact factor: 91.245

3.  Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.

Authors:  R Badaro; E Falcoff; F S Badaro; E M Carvalho; D Pedral-Sampaio; A Barral; J S Carvalho; M Barral-Netto; M Brandely; L Silva
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

4.  Lymphocyte subsets in kala-azar.

Authors:  A Sciotto; G Russo-Mancuso; C M Zinna; F F Comisi; R M Sciannaca; G Schiliro
Journal:  Ann Allergy       Date:  1989-10

5.  Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain.

Authors:  C Montalban; R Martinez-Fernandez; J L Calleja; J D Garcia-Diaz; R Rubio; F Dronda; S Moreno; M Yebra; C Barros; J Cobo
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

6.  Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.

Authors:  H W Murray; M J Oca; A M Granger; R D Schreiber
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

7.  [Visceral leishmaniasis (kala-azar) in acquired immunodeficiency syndrome (AIDS)].

Authors:  G Just; R Simader; E B Helm; W Stille; S Falk; H J Stutte; K Hübner
Journal:  Dtsch Med Wochenschr       Date:  1988-12-09       Impact factor: 0.628

Review 8.  [Visceral leishmaniasis (kala-azar) and HIV infection. Apropos of a case and literature review].

Authors:  J Joggi; J P Chave; D Bruni; P M Schmidt
Journal:  Schweiz Med Wochenschr       Date:  1990-03-24

9.  Visceral leishmaniasis (kala azar) in a patient with AIDS.

Authors:  D Smith; B Gazzard; R P Lindley; A Darwish; C Reed; A D Bryceson; D A Evans
Journal:  AIDS       Date:  1989-01       Impact factor: 4.177

10.  Visceral leishmaniasis as an opportunistic infection in the acquired immunodeficiency syndrome.

Authors:  C Montalban; F Sevilla; A Moreno; R Nash; M L Celma; R F Muñoz
Journal:  J Infect       Date:  1987-11       Impact factor: 6.072

View more
  5 in total

1.  Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi's sarcoma in an AIDS patient.

Authors:  H Albrecht; H J Stellbrink; G Gross; B Berg; U Helmchen; H Mensing
Journal:  Clin Investig       Date:  1994-12

2.  Up-regulation of T helper 2 and down-regulation of T helper 1 cytokines during murine retrovirus-induced immunodeficiency syndrome enhances susceptibility of a resistant mouse strain to Leishmania amazonensis.

Authors:  M Barral-Netto; J S da Silva; A Barral; S Reed
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

3.  Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study.

Authors:  Ermias Diro; Koert Ritmeijer; Marleen Boelaert; Fabiana Alves; Rezika Mohammed; Charles Abongomera; Raffaella Ravinetto; Maaike De Crop; Helina Fikre; Cherinet Adera; Robert Colebunders; Harry van Loen; Joris Menten; Lutgarde Lynen; Asrat Hailu; Johan van Griensven
Journal:  PLoS Negl Trop Dis       Date:  2015-10-02

4.  High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia.

Authors:  Ermias Diro; Lutgarde Lynen; Rezika Mohammed; Marleen Boelaert; Asrat Hailu; Johan van Griensven
Journal:  PLoS Negl Trop Dis       Date:  2014-05-22

Review 5.  Visceral Leishmaniasis and HIV coinfection in East Africa.

Authors:  Ermias Diro; Lutgarde Lynen; Koert Ritmeijer; Marleen Boelaert; Asrat Hailu; Johan van Griensven
Journal:  PLoS Negl Trop Dis       Date:  2014-06-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.